6645.TW Kim Forest Enterprise Co., Ltd.

Healthcare Diagnostics & Research Taiwan Stock Exchange
12.75 TWD
Close of Nov 5, 2026
11.40 20.80
Market cap
TWD 770M
P/E
-
P/B
1.84x
ROE
-36.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6645.TW undervalued?

Graham number

The Graham number of Kim Forest Enterprise Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kim Forest Enterprise Co., Ltd. fundamental analysis

No fundamental analysis for Kim Forest Enterprise Co., Ltd. yet.

Kim Forest Enterprise Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kim Forest Enterprise Co., Ltd.

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company provides genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It offers bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in …

Full company profile